HudsonAlpha welcomes associate company Sulfilatec

HudsonAlpha welcomed Sulfilatec to its growing number of associate companies. Sulfilatec, Inc. is a preclinical-stage biotechnology company aiming to transform clinical outcomes in dialysis. The company is developing novel treatments tailored to the unique biochemical profile of dialysis patients in order to reduce the elevated morbidity and mortality rates associated with dialysis treatments.